人髓核細(xì)胞永生化細(xì)胞
具體成交價(jià)以合同協(xié)議為準(zhǔn)
- 公司名稱 上海富雨生物科技有限公司
- 品牌
- 型號(hào)
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時(shí)間 2025/2/11 23:18:13
- 訪問(wèn)次數(shù) 9
聯(lián)系方式：陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息，謝謝!
人原代髓核細(xì)胞永生化
19156044901 （同微信）
in nulkrous types of advanced cancer. However, the majority of patients do not benefit from this treatlknt modality. Although data are scarce, in general, patients with low-grade neuroendocrine tumours (NETs) do not benefit from treatlknt with ICIs in contrast to patients with neuroendocrine carcinoma, in which a small subgroup of patients may
development of new diagnostic and therapeutic moieties.Cardiovascular diseases and cancer are the most common causes of death in Germany. Cancer treatment can lead to significant cardiovascular side effects and thus form a link between the two disease groups. The focus of
| 種屬 | 人 |
| 組織來(lái)源 | 椎間盤組織 |
| 傳代比例 | 1:2傳代 |
| 培養(yǎng)基配置 | 基礎(chǔ)培養(yǎng)基500ml ；生長(zhǎng)添加劑5ml ；胎牛血清50ml ；雙抗5ml |
| 簡(jiǎn)介 | 髓核 ，是乳白色半透明膠狀體 ，富于彈性 ，為椎間盤結(jié)構(gòu)的一部分 ，位于兩軟骨板與纖維環(huán)之間。由縱橫交錯(cuò)的纖維 網(wǎng)狀結(jié)構(gòu)即軟骨細(xì)胞和蛋白多糖黏液樣基質(zhì)構(gòu)成的彈性膠凍物質(zhì) ，發(fā)育成熟的髓核是一個(gè)由軟骨樣細(xì)胞分散在細(xì)胞間 質(zhì)內(nèi) ，周圍圍繞著一個(gè)比較致密的膠原纖維網(wǎng)的含水球 ，位于椎間盤偏后位置 ，占推間盤橫斷面積的50%～60% ；由 于它的含水量很高 ，并和軟骨終板緊密接觸 ，是椎間盤接受經(jīng)軟骨終板主要營(yíng)養(yǎng)途徑滲透交換營(yíng)養(yǎng)的主要部分。 |
| 形態(tài) | 長(zhǎng)梭形細(xì)胞樣 ，不規(guī)則細(xì)胞樣 |
| 生長(zhǎng)特征 | 貼壁生長(zhǎng) |
| 細(xì)胞檢測(cè) | Ⅱ型膠原熒光染色為陽(yáng)性免疫熒光鑒定 ，細(xì)胞純度可達(dá)90%以上 ，不含有HIV-1、HBV、HCV、支原體、細(xì)菌、酵母 和真菌等。 |
| 倍增時(shí)間 | 每周 2 至 3 次 |
| 備注 | 人原代髓核細(xì)胞永生化通過(guò)慢病毒轉(zhuǎn)染的方式攜帶SV40基因。 |
19156044901 （同微信）
in nulkrous types of advanced cancer. However, the majority of patients do not benefit from this treatlknt modality. Although data are scarce, in general, patients with low-grade neuroendocrine tumours (NETs) do not benefit from treatlknt with ICIs in contrast to patients with neuroendocrine carcinoma, in which a small subgroup of patients may
development of new diagnostic and therapeutic moieties.Cardiovascular diseases and cancer are the most common causes of death in Germany. Cancer treatment can lead to significant cardiovascular side effects and thus form a link between the two disease groups. The focus of
采購(gòu)中心
化工儀器網(wǎng)